Burcon NutraScience Co. (BU) Price Target Increased to C$7.50 by Analysts at Paradigm Capital
Burcon NutraScience Co. (TSE:BU) had its price target lifted by equities researchers at Paradigm Capital from C$7.00 to C$7.50 in a research report issued to clients and investors on Wednesday. The brokerage presently has a “buy” rating on the stock. Paradigm Capital’s price objective would indicate a potential upside of 124.55% from the company’s current price.
Burcon NutraScience (TSE:BU) traded down 3.19% during trading on Wednesday, hitting $3.34. 97,102 shares of the company were exchanged. Burcon NutraScience has a 12 month low of $1.71 and a 12 month high of $3.90. The company’s market capitalization is $119.68 million. The stock’s 50-day moving average is $2.72 and its 200-day moving average is $2.84.
Burcon NutraScience Corporation (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology.
Receive News & Ratings for Burcon NutraScience Co. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Burcon NutraScience Co. and related companies with MarketBeat.com’s FREE daily email newsletter.